FDA to Gather Input on Drug Import Regs at July 12 Meeting
The Food and Drug Administration will hold a meeting on implementation of certain provisions of the Food and Drug Administration Safety and Innovation Act, including standards for admission of imported drugs and commercial drug importers. The July 12 meeting in…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Silver Spring, Md., will include a general overview on FDASIA's Title VII supply chain integrity protections. FDA will also ask for input on the types of information that importers should be required to provide as a condition of admission, as well as registration requirements for commercial drug importers and good importer practices.